Navigate Select ESC Close

Breakthrough Cuts Heart Disease by 25%

2025-12-09 People & Blogs
22.2k
1.3k
153
Dr Brad Stanfield
Dr Brad Stanfield
336.0k subscribers

The Genetic Breakthrough Leading to Oral PCSK9 Inhibitors

Discover the decades-long genetic quest that identified PCSK9, unlocking a major biological switch for lowering dangerous LDL cholesterol. Learn how this knowledge led to injectable breakthroughs and, critically, the recent development of convenient oral treatments.

Short Summary

  • Pinpoint the PCSK9 discovery that provided crystal-clear drug target validation for cholesterol reduction.
  • Confirm that primary prevention trials successfully used PCSK9 inhibitors to prevent the first major cardiovascular events in high-risk patients.
  • A new oral PCSK9 inhibitor now matches the LDL lowering efficacy of previous injectable therapies, promising wider accessibility.

This summary tracks the evolution from identifying the PCSK9 gene mutation in rare families to validating the treatment in large-scale prevention trials, culminating in more accessible delivery methods.

Unlock all features

FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.

Description

For weekly health research summaries and extra insights, sign up here 👉 https://drstanfield.com/pages/sign-up 💊 Supplements I Take: https://drstanfield.com/pages/my-supplements 💊MicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus 💊MicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin Timestamps: 00:00 The Mystery of High Cholesterol Levels 01:11 Discovery of NRC1 and PCSK9 02:06 The Impact of PCSK9 on Cholesterol Levels 04:35 The Success of PCSK9 Inhibitors 06:59 The New VESALIUS-CV Trial 09:18 The Development of Oral PCSK9 Inhibitors 11:06 Conclusion & The Importance of Lifestyle Factors 📜 Roadmap - how to look young & feel strong: https://drstanfield.com/pages/roadmap ✔️ Twitter: https://twitter.com/BradStanfieldMD ✔️ Patreon: https://www.patreon.com/bradstanfieldmd Here are the links to the research papers referenced in the video: https://www.jacc.org/doi/10.1016/j.jacc.2012.08.986 https://www.nejm.org/doi/full/10.1056/NEJMoa1615664 https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 https://jamanetwork.com/journals/jama/article-abstract/2841258 Thumbnail by James Kelly Video edited by Troy Young Script by John Milliken The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.

Top Comments (10)

@nukenet1 2025-12-09

This is me, first heart attack age 35, second at age 38, another Angio at 42, Negative for the genetic markers & statin intolerant and then trials of evolocumab in 2016, still here 9 years after starting Repatha (evolocumab) and my LDL levels are awesome, it's been a real life saver and I'd never of been around long enough to see my daughter grow up. Thanks to everyone involved around the world.

120 22 replies
@suprbent 2025-12-09

You're setting a high bar for Primary care medicine. Rock on!

33
@mdepfl 2025-12-09

Fantastic information, skillfully presented. Thank you.

18
@gamarad 2025-12-05

I'm so excited for enlicitide. Hopefully since it's not a mab and doesn't require an expensive delivery system it will be much cheaper than current PCSK9 inhibitors.

14 3 replies
@MedMan-rk3bq 2025-12-09

You do a great job communicating the story of how these studies happen. Thanks for your hard work

10
@DrBradStanfield 2025-12-09

All 4 studies referenced in the video are linked in the video's description For extra insights + a free health checklist, sign up here 👉 https://drstanfield.com/pages/sign-up

10
@billzen 2025-12-10

Great summary, thanks!

2
@Norsken911 2025-12-11

Great info. Thanks.

1
@Paul-w9r1r 2025-12-12

Thanks Dr. Interesting information, lending itself to potentially having a positive impact for all of us, cardiovascular disease being debilitating and often deadly.

1
@Thearnstonaffect 2025-12-11

Brilliant overview of PCSK9’s discovery reshaping modern cholesterol therapeutics. 🔬

1

Unlock the Data Inside
Turn Videos into Knowledge

  • Get FREE 10/day: transcripts, summaries, chats
  • Chat with videos, export text & PDF
  • $1 free API credit for RAG, chatbots & research

Free forever plan • All features unlocked

App screenshot